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Available online 17 September 2016Induced pluripotent stem cells (iPSCs) were generated from dermal ﬁbroblasts from a 60-year-old
cerebrotendinous xanthomatosis (CTX) patient, carrying a homozygous mutation c. [1183CNA]; p. R395S in
CYP27A1. Episomal plasmids encoding the pluripotency genes OCT4, SOX2, KLF4, L-MYC and LIN28 were intro-
duced via electroporation. The generated line iPS-CTX-R395S has no sign of plasmid integration or chromosomal
aberration and retained the mutation site in CYP27A1. Furthermore, iPSCs express pluripotency markers and are
able to differentiate in all germ layers in vitro. The generated line may be a useful tool for disease modelling of
CTX.
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Cerebrotendinous xanthomatosis (CTX) is an autosomal recessive
lipid storage disease. Mutations in CYP27A1 lead to defects in the mito-
chondrial enzyme sterol 27-hydroxylase involved in the synthesis of
bile acids from cholesterol. A block in this pathway due to loss-of-func-
tionmutations in CYP27A1 leads to high amounts of abnormal lipids like
cholestanol in serumand cerebrospinalﬂuid (CSF) and their subsequent
deposition in the ocular lens resulting in juvenile cataract and in
xanthomas, predominately in tendons. Additional symptoms can in-
clude chronic diarrhea due to lack of bile acids, atherosclerosis, osteopo-
rosis as well as progressive neurological dysfunctions such as ataxia,
dystonia, peripheral neuropathy and dementia (Nie et al., 2014).
In this study, we reprogrammed dermal ﬁbroblasts from a 60-year-
old female CTX patient, carrying a homozygous c. [1183CNA]; p.
R395S mutation in CYP27A1, to induced pluripotent stem cells (iPSCs).
Functional relevance of the mutation was conﬁrmed by massively in-
creased levels of cholestanol (3.41 mg/dl; normal: 0.36 ± 0.09). Epi-
somal plasmids encoding the pluripotency genes OCT4, SOX2, KLF4, L-
MYC and LIN28 were introduced via electroporation (Okita et al.,
2011). The genetic integrity of iPS-CTX-R395S was conﬁrmed by com-
parative SNP analysis with the parental ﬁbroblasts (Fig. 1A),
resequencing of the mutation site (Fig. 1B), and the exclusion of inte-
grated reprogramming plasmids by PCR (Fig. 1C). Gene expression of
the stem cell markers alkaline phosphatase (ALP) (Fig. 2A), OCT4, and
NANOG (Fig. 2B) was shown by enzymatic activity or immunocyto-
chemistry. Expression of OCT4, SOX2, KLF4, c-MYC, NANOG, DNMT3B
and TDGF1 was veriﬁed by qRT-PCR in comparison to the human em-
bryonic stem cell lines HuES-H6 and HuES-H9 and ﬁbroblasts (Fig.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Genomic characterization of iPS-CTX-R395S. (A) Comparison of SNP array analysis of theﬁbroblast line F-CTX-R395S and the iPSC line iPS-CTX-R395S shows chromosomal integrity
after reprogramming. Data is represented as the weighted log2 ratio of the copy number on the left Y-axis (blue line) and the chromosome number on the X-axis. (B) Electropherograms
conﬁrm the patient-speciﬁc homozygous pointmutation c.1183CNA. (C) Absence of integrated plasmids identiﬁed by PCRwith DNA from iPS-CTX-R395S, the reprogramming plasmids as
positive control, and water as negative control using plasmid-speciﬁc primers for OCT3/4, SOX2, KLF4, and L-MYC.
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of the generated line to differentiate into all three germ layers. Ectoder-
mal lineage was proven by neuronal cells expressing β-III-Tubulin, en-
dodermal lineage by cells expressing α-Fetoprotein, and mesodermal
lineage bymuscle cells expressing smoothmuscle actin (SMA) (Fig. 2D).
Materials and methods
Reprogramming of ﬁbroblast to iPSCs
The patient's skin biopsywas dissected and subsequently cultured in
Dulbecco's modiﬁed eagle's medium (DMEM) high glucose (Life Tech-
nologies) with 10% fetal bovine serum (FBS, Life Technologies) for
around 10 days at 37 °C and 5% CO2 with medium changes every 2–
3 days until ﬁbroblasts grew out of the biopsy. Reprogramming was
achieved by electroporation of 1 × 105 ﬁbroblasts using a Nucleofector
2D (Lonza) and 1 μg of each plasmid pCXLE-hOCT3/4, pCXLE-hSK, and
pCXLE-hUL (Okita et al., 2011). After 1 day in DMEM+ 10% FBS, 2 μg/l
ﬁbroblast growth factor 2 (FGF2, Peprotech) was added to themedium.Fromday 3 on cells were cultured in essential 8 (E8)mediumconsisting
of DMEM/F12 (Life Technologies), 64 mg/l L-ascorbic acid 2-phosphate
sesquimagnesium salt hydrate (Sigma-Aldrich), 1× ITS-Supplement
(Life Technologies), 10 μg/l FGF2, 2 μg/l TGF-β-1 (Peprotech), 100 μg/l
heparin (Sigma-Aldrich), and 100 μM Na-butyrate (NaB) (Sigma-Al-
drich) with medium change every other day. Three to four weeks after
reprogramming iPSC colonies were picked manually and transferred
to Matrigel (Corning)-coated 6-well plates for further expansion. Cells
were split with 0.02% EDTA in PBS at ratios between 1:6 and 1:12
until reaching passage 5–10 when further analysis was carried out.SNP array analysis
DNA was isolated from iPSCs and the original ﬁbroblast line using
the DNeasy blood & tissue kit (Qiagen) according to manufacturer's
guidelines. 2 μg of each DNA was analyzed using the Affymetrix
CytoScan HD technology (Affymetrix) and raw data was visualized
with the Affymetrix Chromosome Analysis Suite (ChAS) 2.0 software.
Fig. 2. Functional characterization of iPS-CTX-R395S by (A) alkaline phosphatase staining (ALP). (B) Immunocytochemical staining of OCT4 (green) and NANOG (red). Nuclei are
counterstained with DAPI (blue). Scale bar = 50 μm. (C) qRT-PCR-based expression analysis of stem cell markers OCT4, SOX2, KLF4, c-MYC, NANOG, DNMT3B, TDGF1, and REX1.
Expression is normalized to the reference gene GAPDH and in relation to the human embryonic stem cell line HuES-H6. (D) Immunocytochemical staining of in vitro differentiated
iPSCs expressing markers of all germ layers, β-III-Tubulin (TUJ, ectoderm), α-Fetoprotein (AFP, endoderm), and SMA (smooth muscle actin, mesoderm). Nuclei are counterstained
with DAPI (blue). Scale bar is 100 μm for TUJ and 50 μm for AFP and SMA.
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The mutation site [c.1183CNA] in the CYP27A1 gene was Sanger se-
quenced on a 3130xl Genetic Analyzer (Applied Biosystems). A primer
pair ﬂanking the mutation site was used for PCR and the Amplicon
was analyzed with the Staden 2.0.0b10 software (Staden Sourceforge).Table 2
Primers used for validation of pluripotency genes.
Forward sequence Reverse sequenceNon-integration of transgenes
DNAwas isolated from iPS-CTX-R395S using theDNeasy blood& tis-
sue kit (Qiagen) according to manufacturer's guidelines. PCR reactionsTable 1
Primers (Okita et al. 2011) used for integration analysis by PCR.
Forward sequence Reverse sequence
KLF4 CCACCTCGCCTTACACATGAAG TAGCGTAAAAGGAGCAACATAG
L-MYC GGCTGAGAAGAGGATGGCTAC TTTGTTTGACAGGAGCGACAAT
OCT3/4 CATTCAAACTGAGGTAAGGG TAGCGTAAAAGGAGCAACATAG
SOX2 TTCACATGTCCCAGCACTACCAG TTTGTTTGACAGGAGCGACAATwere conductedwith theGoTaqG2DNAPolymerase (Promega) accord-
ing to manufacturer's instruction. As a positive control, the three plas-
mids applicated for reprogramming were used (primer sequences are
listed in Table 1). PCR products were analyzed by gel electrophoresis
on a 2% agarose gel using Midori Green as a dye. As a size ladder Gene
Ruler DNA ladder was used.c-MYC ATTCTCTGCTCTCCTCGACG CTGTGAGGAGGTTTGCTGTG
DNMT3 ACGACACAGAGGACACACAT AAGCCCTTGATCTTTCCCCA
GAPDH AGGTCGGAGTCAACGGATTT ATCTCGCTCCTGGAAGATGG
KLF4 CCATCTTTCTCCACGTTCGC CGTTGAACTCCTCGGTCTCT
NANOG CAAAGGCAAACAACCCACTT TGCGTCACACCATTGCTATT
OCT4 GGAAGGTATTCAGCCAAACG CTCCAGGTTGCCTCTCACTC
REX1 AACGGGCAAAGACAAGACAC AACTCACCCCTTATGACGCA
SOX2 TGATGGAGACGGAGCTGAAG GCTTGCTGATCTCCGAGTTG
TDGF1 GGTCTGTGCCCCATGACA AGTTCTGGAGTCCTGGAAGC
Table 3
Antibodies used for validation of pluripotency genes and in vitro differentiation potential.
Antibody Dilution Manufacturer
Pluripotency Goat anti-OCT4 1:100 Santa-Cruz
Rabbit anti-NANOG 1:50 Stemgent
In vitro differentiation Mouse anti-AFP 1:200 Sigma-Aldrich
Mouse anti-SMA 1:100 Dako
Mouse anti-TUJ 1:1000 Sigma-Aldrich
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iPSCs were cultivated on 12-well plates until conﬂuency of 60–80%.
Cells were ﬁxed in 4% paraformaldehyde (PFA) for 1 min and washed
3 times with phosphate buffered saline (PBS). Cells were stained for
30min in 40 μl Naphthol AS-MX phosphate alkaline solution (Sigma-
Aldrich) and 1 ml Fast Red (1 mg/ml, Sigma Aldrich). ALP-positive colo-
nies were stained dark red and the staining solutionwas replaced by PBS.
Immunocytochemical staining
iPSCs were cultured on coverslips in 24-well plates until a
conﬂuency of 60–80%. For staining, cells were ﬁxed in 4% paraformalde-
hyde (PFA) for 15 min followed by three washing steps with PBS. Cells
were incubated in PBS, 1% FCS, and 0.1% Triton X-100 for 45 min for
blocking and permeabilization. The primary antibodies (Table 3) were
applied for 1 h at RT followed by three timeswashing in PBS, incubation
of secondary antibodies Alexa Fluor 488 or Alexa Fluor 568 (1:300) for
1 h at RT in the dark and again three washing steps in PBS. DAPI
(1:5000) was used for nuclear counterstaining. Finally, cells were em-
bedded in mounting medium (Dako) and imaged with Axio Imager Z1
with ApoTome (Zeiss).qRT-PCR of pluripotency marker
Total RNA was isolated from cell samples using the high Pure RNA
isolation Kit (Roche) following cDNA synthesis by reverse transcription
using the Transcriptor High Fidelity cDNA Synthesis Kit according to the
manufacturer's guidelines. For further analysis, cDNA was diluted 1:10
and the qPCR reactions were prepared with LightCycler 480 SYBR
Green I Master Kit (Roche) and executed on a LightCycler 480
(Roche). The experiments were performed as triplicates and analyzed
using the ΔΔCT method with GAPDH as a reference gene and hESC
line HuES-H6 for normalization (Table 2) .
In vitro differentiation potential
The differentiation potential of iPS-CTX-R395S was investigated by
embryoid body (EB) formation. Therefore, iPSCs were detached from
the cell culture plate and cultured in Aggrewell800 plates (Stemcell
Technologies) in EB medium (80% DMEM/F12 (Life Technologies), 20%
KOSR, 1× NEAA, 1× Pen/Strep, 2 mM L-Glutamine and 0.1 mM 2-
Mercaptoethanol). After two days, EBs were transferred to gelatine
(0.1% in sterile ddH2O) coated 24-well plates and cultivated in EBmedi-
um. Medium was changed every other day for two weeks. Cells were
ﬁxed in 4% PFA for 15 min and stained for germ layer speciﬁc markers,
namely β-III-Tubulin (ectoderm), α-Fetoprotein (endoderm), and
smooth muscle actin (mesoderm) (see Table 3).
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